A Clinical Trial to see the effect of some Ayurvedic Formulation in the treatment of Vataja Abhishyanda with reference to Allergic Conjunctivitis

Randomized Clinical Controlled Trial to study the effect of Bilva Panchmooladi Kwath Siddha Ghrita Aschyotana and Olopatadine Eye Drops in Vataja Abhishyanda.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014474

Enrollment

Registered

2018-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vataja Abhishyanda, Allergic Conjunctivitis

Interventions

Intervention1: Bilva Panchamooladi Kwath Siddha Ghrita Aschyotana: Bilva,Agnimantha,Shonyak,Patala,Gambhari,Brihati,Eranda,Shigru Siddha Ghrita Dose-1drop twice a day Frequency-Twice a day Administrat

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms of Vataja Abhishyanda-Toda,Sangharsha,Shishirashruta,Alpa shopha

Exclusion criteria

Exclusion criteria: Pittaja,Kaphaja,Raktaja Abhishyanda other complications like corneal opacity,corneal ulcer Systemic diseases like Broncheal Asthama,Allergic Bronchitis,Dermatitis,Allergic Rhinitis,DM,HTN etc will be excluded.

Design outcomes

Primary

Measure	Time frame
Effect of Bilva Panchmooladi kwath siddha ghrita in vataja abhishyanda.Timepoint: The drug will be given for 10 days. The patients will be assessed before and after treatment. Total duration of study will be 18 months.	—

Secondary

Measure	Time frame
To get relief from symptoms of Vataja AbhishyandaTimepoint: 18 months	—

Countries

India

Contacts

Public ContactVd Supriya Suryakant Muddalwar

Sumatibhai Shah Ayurved Mahavidyalaya

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026